𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of childhood acute lymphoblastic leukemia with intermediate-dose cytosine arabinoside and adriamycin

✍ Scribed by Ishii, Eiichi ;Hara, Toshiro ;Ohkubo, Kenshi ;Matsuzaki, Akinobu ;Takeuchi, Takami ;Veda, Kohji


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
389 KB
Volume
14
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Treatment of acute nonlymphocytic leukem
✍ Letendre, Louis ;Niedringhaus, Robert D. ;Therneau, Terry M. ;Gastineau, Dennis πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 362 KB πŸ‘ 1 views

Effective treatment of the elderly patients (265 years) with acute nonlymphocytic leukemia (ANLL) remains elusive and controversial. In the present study, single-agent Cytosine Arabinoside (AM-C) was administered at an intermediate dose level (500 mg/m2 intravenously [I.V.] I-hour infusion q12 hours

Cytosine arabinoside in acute leukemia o
✍ D. G. Traggis; A. Dohlwitz; L. Das; N. Jaffe; W. C. Moloney; T. C. Hall πŸ“‚ Article πŸ“… 1971 πŸ› John Wiley and Sons 🌐 English βš– 304 KB πŸ‘ 2 views
Chemotherapy with cyclophosphamide, vinc
✍ Sallan, Stephen E. ;Camitta, Bruce M. ;Chan, David M. ;Traggis, Demitrius ;Jaffe πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 290 KB

## Abstract Three groups of children with acute lymphoblastic leukemia (ALL) were treated with intermittent cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP). Group A (no prior relapse) and Group B (prior single‐agent relapse) received COAP after 12 months on another chemot